Characteristics Number % Event
TB smear
Not determined 103 19.81 10
Negative 346 66.54 28
Positive 71 13.65 13
Original Regimen
d4t (30)-3TC-NVP 161 30.96 15
d4t (40)-3TC-NVP 101 19.42 8
d4t (30)-3TC-EFV 139 26.73 8
d4t (40)-3TC-EFV 93 17.88 16
AZT-3TC-NVP 21 4.04 4
AZT-3TC-EFV 5 0.96 0
CD4 count ( cells/mm3)
≤50 96 18.46 14
51-100 101 19.42 11
101-200 207 39.81 14
≥201 116 22.31 12
Cotimoxazole
Yes 429 82.50 41
No 91 17.50 10
Weight (Kg)
≤40 97 18.65 12
40-50 225 43.27 23
50-60 147 28.27 13
>60 51 9.81 3
Functional status
Working 265 50.96 17
Ambulatory 214 41.15 30
Bedridden 41 7.88 4
WHO stage
Stage I 33 6.35 3
Stage II 83 15.96 3
Stage III 336 64.62 39
Stage IV 68 13.08 6
Hemoglobin (g/dl)
≤11 223 42.88 14
>11 297 57.12 37
D4T: Stavudine; EFV: Efavirenz; AZT: Zidovudine; NVP: Nevirapine; 3TC: Lamiduvine;
Table 2: Base line Patients’ Clinical characteristics, 2006-2011, Aksum St. Merry Hospital.
Goto home»